The nation of Zimbabwe has turned down a major US healthcare agreement worth 367 million US dollars (£272m) spanning five years because of the United States' insistence on sensitive information.
This move became public after a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesman later clarified that the United States was demanding access to health data for scientific study and commercial gain but was unwilling to share the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for more negotiations to find a deal acceptable to all parties so the nation's critical HIV programme can continue.
Wider Context
Zimbabwe's decision follows a similar case in Kenya, where a high court blocked a related deal with the US following concerns were filed about the security of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and accountability.
As per reports, 16 African countries have to date agreed to these new agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Effectively, our country would provide the basic resources for medical research with no assurance that the final treatments would be available to our citizens if a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending frameworks previously set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This framework is intended to guarantee that when a nation contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome continued dialogue with our US partners on how future co-operation could be designed in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that negotiations need to persist since a large portion of the nation's HIV programmes were funded by external financing.
"In cases where specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," it added.
The halted deal underscores the continuing debate between accepting crucial international aid and safeguarding a country's data in an increasingly data-driven world.